Express Scripts Rolls Out Drug Discount Program for Newly Uninsured With Chart: Participating Brand-Name Drugs in Express Scripts’ Parachute Rx

Promising “extraordinary prescription savings for extraordinary times,” Express Scripts on May 7 unveiled a new program that offers medication discounts for Americans who lose their health coverage amid the economic damage wrought by the COVID-19 pandemic. The discounted prices — $25 for a 30-day supply of generics and $75 for a 30-day supply of select brand-name medications — are available to former Express Scripts members and eligible non-members alike, either through mail order or at more than 50,000 participating pharmacies.

The concept of offering discount drugs to the general public isn’t exactly new, observes Ashraf Shehata, KPMG’s national sector leader for health care and life sciences. After all, “the old $5 generics and other programs like that were quite popular” at retail chains, he tells AIS Health. Companies such as CVS Health Corp. and Walgreen Co. also found success with retail pharmacy discount card programs, he points out.

© 2024 MMIT
Leslie Small

Leslie Small

Leslie has been working in journalism since 2009 and reporting on the health care industry since 2014. She has covered the many ups and downs of the Affordable Care Act exchanges, the failed health insurer mega-mergers, and hundreds of other storylines spanning subjects such as Medicaid managed care, Medicare Advantage, employer-sponsored insurance, and prescription drug coverage. As the managing editor of Health Plan Weekly and Radar on Drug Benefits, she writes and edits for both publications while overseeing a small team of reporters who also focus on the managed care sector. Before joining AIS Health, she was a senior editor for the e-newsletter Fierce Health Payer, and she started her career as a copy editor at multiple local newspapers. She graduated with a dual degree in journalism and political science from Penn State University.

Related Posts

businessman-viewing-news-update-journalism-headline-on-a-laptop
June 13

News Briefs: State Officials Urge SCOTUS Review of PBM Regulation Case

READ MORE
scientist-in-lab
June 13

Midsize Plans Struggle to Pay for Cell, Gene Therapies, Execs Say

READ MORE
injector-pen
June 13

Medicaid Programs Are Slow to Cover GLP-1s, but That Could Soon Change

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today